 |
인쇄하기
취소
|
Jinyang to patent an anti-cancer therapy in America.
Jinyang pharmaceutical company, a Kosdaq listed company of Korea, announced that the company took a patent registration of an anti-leukemia drug in the United States under the number of Pat. No. 6989143.
The company said that the patent titled "Removing method of plasma ascorbate" characterized in which the new compound involved with a biologically inactive polymer in the plasma to remove ...
The company said that the patent titled "Removing method of plasma ascorbate" characterized in which the new compound involved with a biologically inactive polymer in the plasma to remove ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.